Welcome to our dedicated page for Gevo SEC filings (Ticker: GEVO), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Gevo, Inc. filings document the company’s renewable-fuels business, Nasdaq-listed common stock, operating results and material corporate events. Form 8-K reports include quarterly and annual financial results, business updates for low-carbon ethanol, carbon management, synthetic aviation fuel initiatives, and material financing or refinancing arrangements involving company subsidiaries.
Proxy and governance filings cover director elections, board composition, auditor ratification, executive compensation votes and officer transitions. The filing record also documents credit agreements, working-capital facilities, renewable natural gas project debt matters, compensatory arrangements and other disclosures related to Gevo’s capital structure, governance and project-development strategy.
Gevo, Inc. executive Andrew Shafer, Chief Customer Marketing & Brand Officer, exercised stock options for 5,550 shares of common stock at $0.71 per share and on the same day sold 5,550 shares at a weighted average price of $2.7076 per share. The transactions were carried out under a Rule 10b5-1 trading plan adopted on November 19, 2025, indicating they were pre-planned. Following these moves, Shafer directly holds 270,823 shares of common stock and indirectly holds 16,871.52 shares through a 401(k) plan, where 6.17 shares were disposed between March 10 and April 1, 2026 to cover administrative fees, showing the net sale is small relative to his remaining stake.
Gevo, Inc. President & COO Ryan Christopher Michael reported open-market sales of company common stock. On March 30, 2026, he sold 100,000 shares at a weighted average price of $2.7574 per share. On March 31, 2026, he sold an additional 29,797 shares at a weighted average price of $2.9592 per share.
The filing notes these transactions were carried out under a Rule 10b5-1 trading plan adopted on November 19, 2025, indicating they were pre-scheduled. Following the sales, he directly holds 1,402,141 shares of Gevo common stock and indirectly holds 27,888.95 shares through a 401(k) plan.
GEVO reported a proposed sale of Common Stock totaling 200,000 shares in a Form 144 notice. The filing lists an aggregate value of $551,480.00 and references Nasdaq. The excerpt also itemizes restricted stock units granted on 08/20/2022, 07/26/2023, 07/06/2021, and 07/06/2022 with separate share counts.
The notice appears administrative: it lists the securities to be sold and equity compensation awards but does not describe buyer identity, execution method, or timing beyond the Form 144 record.
Gevo Inc — The Vanguard Group filed Amendment No. 6 to a Schedule 13G/A stating it beneficially owns 0 shares of Gevo common stock as reported in the filing dated 03/13/2026. The filing explains an internal realignment on 01/12/2026 that led subsidiaries and business divisions to report disaggregated ownership, and it states The Vanguard Group, Inc. no longer is deemed to beneficially own securities held by those subsidiaries. The filing is signed by Ashley Grim, Head of Global Fund Administration, dated 03/26/2026.
Gevo, Inc. reported that director Angelo Amorelli has informed the Board that he will not stand for re-election at the company’s 2026 Annual Meeting of Stockholders. He will continue to serve as a director until his current term expires at the Annual Meeting.
The company stated that Dr. Amorelli’s decision is for personal reasons and not due to any disagreement with Gevo regarding its operations, policies, or practices. Gevo expressed its appreciation for his dedicated service and contributions to the Board and the company.
Gevo, Inc. director Gary W. Mize reported an open-market sale of 107,100 shares of common stock. The shares were sold on March 12, 2026 at a weighted average price of $2.335 per share, in multiple trades ranging from $2.33 to $2.34.
After this transaction, Mize directly holds 281,226 Gevo shares. The filing characterizes the transaction as a sale in the open market or a private transaction.
Gevo, Inc. Chief Customer, Marketing & Brand Officer Andrew Shafer exercised stock options and sold the resulting shares under a pre-set trading plan. On March 10, 2026, he exercised options for 5,550 shares of common stock at $0.71 per share and sold 5,550 shares at a weighted average price of $2.2063 per share, in multiple trades between $2.185 and $2.23.
The transactions were executed pursuant to a Rule 10b5-1 trading plan adopted on November 19, 2025, indicating they were pre-scheduled. Following these transactions, he holds 270,823 shares directly and 16,877.69 shares indirectly through a 401(k) plan, reflecting a relatively small sale versus his overall position.
Gevo, Inc. Chief Public Affairs Officer Lindsay Clinton Fitzgerald reported an open-market sale of 20,000 shares of common stock on March 12, 2026 at a weighted average price of $2.5062 per share, with individual trade prices ranging from $2.50 to $2.515 per share.
The sale was carried out under a pre-arranged Rule 10b5-1 trading plan adopted on December 1, 2025. After this transaction, Fitzgerald directly holds 212,199 shares and indirectly holds 20,624.27 shares through a 401(k) plan, indicating the sale represents only a portion of his overall position.
GEVO submitted a Form 144 notice to sell 29,800 shares of Common Stock tied to Restricted Stock Units, with an effective grant/vesting date of 11/01/2024 and a filing location noted as Nasdaq. The filing also reports a prior sale of 5,000 shares on 01/20/2026 for $9,940.
This filing is a notification of proposed resale under Rule 144 and does not by itself indicate completion of the listed sale. Cash-flow treatment for the proposed sale is shown as Cash.